UroGen Pharma URGN Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's change in lease liabilities?
- UroGen Pharma (URGN) reported change in lease liabilities of -$53K in Q1 2026.
- How has UroGen Pharma's change in lease liabilities changed year-over-year?
- UroGen Pharma's change in lease liabilities increased by 92.8% year-over-year, from -$738K to -$53K.
- What is the long-term trend for UroGen Pharma's change in lease liabilities?
- Over 2 years (2022 to 2024), UroGen Pharma's change in lease liabilities has grown at a -4.1% compound annual growth rate (CAGR), from -$1.13M to -$1.03M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.